Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APOQUEL DIN 02427893

Status: Marketed
Holder: ZOETIS CANADA INC
Molecule: OCLACITINIB (OCLACITINIB MALEATE)

Health Canada record

Active ingredient(s)OCLACITINIB (OCLACITINIB MALEATE) 5.4 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassVeterinary
ATC
Original market date10-Mar-2016
Current status date10-Mar-2016
SourceHealth Canada DPD

Establishment licence of the holder

Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing OCLACITINIB (OCLACITINIB MALEATE)

DINProductCompanyFormStrengthStatus
02427885APOQUELZOETIS CANADA INCTabletOCLACITINIB (OCLACITINIB MALEATE) 3.6 MGMarketed
02427907APOQUELZOETIS CANADA INCTabletOCLACITINIB (OCLACITINIB MALEATE) 16 MGMarketed
02530651APOQUELZOETIS CANADA INCTablet (Chewable)OCLACITINIB (OCLACITINIB MALEATE) 3.6 MGMarketed
02530678APOQUELZOETIS CANADA INCTablet (Chewable)OCLACITINIB (OCLACITINIB MALEATE) 5.4 MGMarketed
02530686APOQUELZOETIS CANADA INCTablet (Chewable)OCLACITINIB (OCLACITINIB MALEATE) 16 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
295542022-11-28Supplement to a New Drug Submission (SNDS)Addition of drug substance manufacturing and testing site
158112014-07-15New Drug Submission (NDS)
Request a quote for APOQUEL

How to read a Canadian DIN record